Baker Kevin Paul 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 7, 2018
Insider Transaction Report
Form 4
Baker Kevin Paul
SVP, Development Sciences
Transactions
- Tax Payment
Common Stock
2018-02-05$18.42/sh−930$17,131→ 74,684 total
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 7, 2018
Common Stock